Abstract
The unrestrained growth of tumor cells is generally attributed to mutations in essential growth control genes, but tumor cells are also influenced by signals from the environment. In multiple myeloma (MM), the factors and signals coming from the bone marrow microenvironment are possibly even essential for the growth of the tumor cells. As targets for intervention, these signals may be equally important as mutated oncogenes. Given their oncogenic potential, WNT signals form a class of paracrine growth factors that could act to influence MM cell growth. In this paper, we report that MM cells have hallmarks of active WNT signaling, whereas the cells have not undergone detectable mutations in WNT signaling genes such asadenomatous polyposis coliand β-catenin(CTNNB1). We show that the malignant MM plasma cells overexpress β-catenin, including its N-terminally unphosphorylated form, suggesting active β-catenin/T cell factor-mediated transcription. Further accumulation and nuclear localization of β-catenin, and/or increased cell proliferation, was achieved by stimulation of WNT signaling with either Wnt3a, LiCl, or the constitutively active S33Y mutant of β-catenin. In contrast, by blocking WNT signaling by dominant-negative T cell factor, we can interfere with the growth of MM cells. We therefore suggest that MM cells are dependent on an active WNT signal, which may have important implications for the management of this incurable form of cancer.
Bibliography
Derksen, P. W. B., Tjin, E., Meijer, H. P., Klok, M. D., Mac Gillavry, H. D., van Oers, M. H. J., Lokhorst, H. M., Bloem, A. C., Clevers, H., Nusse, R., van der Neut, R., Spaargaren, M., & Pals, S. T. (2004). Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proceedings of the National Academy of Sciences, 101(16), 6122â6127.
Authors
13
- Patrick W. B. Derksen (first)
- Esther Tjin (additional)
- Helen P. Meijer (additional)
- Melanie D. Klok (additional)
- Harold D. Mac Gillavry (additional)
- Marinus H. J. van Oers (additional)
- Henk M. Lokhorst (additional)
- Andries C. Bloem (additional)
- Hans Clevers (additional)
- Roel Nusse (additional)
- Ronald van der Neut (additional)
- Marcel Spaargaren (additional)
- Steven T. Pals (additional)
References
48
Referenced
256
10.1038/nrc746
10.1182/blood.V99.4.1405
10.1016/0092-8674(82)90409-3
10.1016/S0092-8674(00)00122-7
10.1101/gad.14.15.1837
10.1016/S0092-8674(00)81333-1
10.1038/374070a0
10.1016/S1074-7613(00)00004-2
10.1016/S0092-8674(02)01014-0
10.1038/nature01593
10.1146/annurev.cellbio.14.1.59
10.1126/science.1071549
10.1016/S0092-8674(00)80112-9
10.1038/382638a0
10.1038/18884
10.1126/science.281.5382.1509
10.1016/S0002-9440(10)65297-2
- Boon, E. M., Van der Neut, R., van de Wetering, M., Clevers, H. & Pals, S. T. (2002) Cancer Res. 62, 5126-5128.12234972 / Cancer Res. (2002)
10.1101/gad.5.5.880
10.1002/j.1460-2075.1991.tb07928.x
10.1101/gad.5.4.656
10.1016/S0092-8674(02)00702-X
-
Schilham, M. W., Wilson, A., Moerer, P., Benaissa-Trouw, B. J., Cumano, A. & Clevers, H. C. (1998) J. Immunol. 161, 3984-3991.9780167
(
10.4049/jimmunol.161.8.3984
) / J. Immunol. (1998) 10.1016/S1074-7613(00)80454-9
10.1038/ni0901-863
10.1038/90623
10.1093/embo-reports/kvf002
10.1074/jbc.M111635200
10.1182/blood.V83.12.3654.3654
10.1016/S0165-4608(98)00157-5
10.1007/BF01000590
10.1182/blood.V67.6.1542.1542
10.1002/ijc.2910360217
10.1046/j.1365-2443.1998.00221.x
10.1038/nature01611
10.1016/S0092-8674(00)81925-X
10.1126/science.275.5307.1784
-
Koopman, G., Keehnen, R. M., Lindhout, E., Newman, W., Shimizu, Y., van Seventer, G. A., de Groot, C. & Pals, S. T. (1994) J. Immunol. 152, 3760-3767.7511659
(
10.4049/jimmunol.152.8.3760
) / J. Immunol. (1994) 10.1084/jem.180.1.329
10.1016/S0960-9822(02)70790-2
-
Rohrer, J. W., Vasa, K. & Lynch, R. G. (1977) J. Immunol. 119, 861-866.330758
(
10.4049/jimmunol.119.3.861
) / J. Immunol. (1977) 10.1182/blood.V89.10.3624.3624_3624_3635
10.1182/blood.V92.9.3189.421k45_3189_3202
10.1073/pnas.96.20.11464
10.1038/sj.onc.1206239
10.1182/blood.V91.1.3.3_3_21
10.1182/blood.V99.5.1745
10.1038/sj.leu.2402875
Dates
Type | When |
---|---|
Created | 21 years, 4 months ago (April 5, 2004, 8:54 p.m.) |
Deposited | 2 years, 4 months ago (April 28, 2023, 2:46 a.m.) |
Indexed | 5 minutes ago (Sept. 3, 2025, 6:48 a.m.) |
Issued | 21 years, 4 months ago (April 5, 2004) |
Published | 21 years, 4 months ago (April 5, 2004) |
Published Online | 21 years, 4 months ago (April 5, 2004) |
Published Print | 21 years, 4 months ago (April 20, 2004) |
@article{Derksen_2004, title={Illegitimate WNT signaling promotes proliferation of multiple myeloma cells}, volume={101}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0305855101}, DOI={10.1073/pnas.0305855101}, number={16}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Derksen, Patrick W. B. and Tjin, Esther and Meijer, Helen P. and Klok, Melanie D. and Mac Gillavry, Harold D. and van Oers, Marinus H. J. and Lokhorst, Henk M. and Bloem, Andries C. and Clevers, Hans and Nusse, Roel and van der Neut, Ronald and Spaargaren, Marcel and Pals, Steven T.}, year={2004}, month=apr, pages={6122–6127} }